Myasthenia gravis in childhood

Acta Paediatrica, International Journal of Paediatrics

Volumn 85, Issue 7, 1996, Pages 838-842

  Anlar, B ^a   Ozdirim E ^a   Renda, Y ^a   Yalaz, K ^a   Aysun, S ^a   Topcu M ^a   Topaloglu H ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Acetylcholine receptor; acetylcholine receptor antibodies; autoimmunity; myasthenia gravis

Indexed keywords

CHOLINERGIC RECEPTOR; CHOLINERGIC RECEPTOR ANTIBODY; CHOLINESTERASE INHIBITOR; EDROPHONIUM; IMMUNOSUPPRESSIVE AGENT; NEOSTIGMINE;

ADOLESCENT; ANTIBODY TITER; ARTICLE; CHILD; CLINICAL FEATURE; DISEASE SEVERITY; ELECTROMYOGRAPHY; FEMALE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MUSCLE ACTION POTENTIAL; MYASTHENIA GRAVIS; NERVE STIMULATION; PRIORITY JOURNAL; RADIOIMMUNOPRECIPITATION; REMISSION; THYMECTOMY;

EID: 0029793734     PISSN: 08035253     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1651-2227.1996.tb14162.x     Document Type: Article

References (21)

1. Engel AG, Walls TJ, Nagel A, Uchitel O. Newly recognized congenital myasthenic syndromes: I. Congenital paucity of synaptic vesicles and reduced quantal release. II. High-conductance fast-channel syndrome. III. Abnormal acetylcholine receptor. IV. AChR deficiency and short channel-open time. Prog Brain Res 1990;84:125-37
2. Bundey S. A genetic study of infantile and juvenile myasthenia gravis. J Neurol Neurosurg Psychiatry 1972;35:41-51
3. Janas JS, Barohn RJ. A clinical approach to the congenital myasthenic syndromes. J Child Neurol 1995;10:168-69
4. Vincent A, Newsom-Davis J. Acetylcholine receptor antibody characteristics in myasthenia gravis. I. Patients with generalized myasthenia or disease restricted to ocular muscles. Clin Exp Immunol 1982;49:257-65
5. Szobor A. Myasthenia gravis: familial occurrence in a study of 1100 myasthenia gravis patients. Acta Med Hung 1989;46:13-21
6. Bergoffen J, Zmijewski CM, Fishbeck KH. Familial autoimmune myasthenia gravis. Neurology 1994;44:551-4
7. Andrews PI, Massey JM, Sanders DB. Acetylcholine receptor antibodies in juvenile myasthenia gravis. Neurology 1993;43: 977-82
8. Engel AE, Lambert EH, Mulder DM, et al. A newly recognized congenital myasthenic syndrome attributed to a prolonged open time of the acetylcholine-induced ion channel. Ann Neurol 1982;11:553-69
9. Oosterhuis HJGH, Kuks JBM. Myasthenia gravis and myasthenic syndromes. Curr Opin Neurol Neurosurg 1992;5:638-44
10. Millichap JG, Dodge PR. Diagnosis and treatment of myasthenia gravis in infancy, childhood, and adolescence. Neurology 1960;10:1007-14
11. Andrews PI, Massey JM, Howard JF, Sanders DB. Race, sex, and puberty influence onset, severity and outcome in juvenile myasthenia gravis. Neurology 1994;44:1208-14
12. Somnier FE. Clinical implementation of anti-acetylcholine receptor antibodies. J Neurol Neurosurg Psychiatry 1993;56: 496-504
13. Lindstrom JM, Seybold ME, Lennon VA Antibody to acetylcholine receptor in myasthenia gravis. Prevalence, clinical correlates, and diagnostic value. Neurology 1976;26:1054-9
14. Afifi AK, Bell WE. Tests for juvenile myasthenia gravis: comparative diagnostic yield and prediction of outcome. J Child Neurol 1993;8:403-11
15. Morel E, Raimond F, Goulon-Goeau C, et al. Le dosage des anticorps anti-recepteurs de l'acetylcholine dans la myasthenie. Nouv Presse Med 1982;11:1849-54
16. Wu H, An J, Xu Y. Childhood myasthenia gravis in China [abstract]. Brain Dev 1990;12:700.
17. Vincent A, Newsom-Davis J. Acetylcholine receptor antibody as a diagnostic test for myasthenia gravis: results in 153 validated cases and 2967 diagnostic assays. J Neurol Neurosurg Psychiatry 1985;48:1246-52
18. Tindall RSA. Humoral immunity in myasthenia gravis: effect of steroids and thymectomy. Neurology 1980;30:554-7
19. Vincent A, Newsom-Davis J, Newton P, Beck N. Acetylcholine receptor antibody and clinical response to thymectomy in myasthenia gravis. Neurology 1983;33:1276-82
20. Kuroda Y, Oda K, Neshige R, Shibasaki H. Exacerbation of myasthenia gravis after removal of a thymoma having a membrane phenotype of suppressor T cells. Ann Neurol 1984;15: 400-2
21. Soliven B. Seronegative myasthenia gravis. Neurology 1988;38: 514-7